Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.

Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, Steppan S, Volsek M, Kribben A, Nierhaus M, Jankowski V, Zidek W, Jankowski J.

Am J Nephrol. 2012;35(1):31-9. doi: 10.1159/000334742. Epub 2011 Dec 15.

PMID:
22179063
2.

Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.

Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG.

Nephrol Dial Transplant. 2008 Feb;23(2):586-93. Epub 2007 Oct 12.

PMID:
17933842
3.

Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis.

Zaher MM, Abdel-Salam M, Abdel-Salam R, Sabour R, Morsy AA, Gamal D.

Saudi J Kidney Dis Transpl. 2016 Mar;27(2):233-40. doi: 10.4103/1319-2442.178205.

4.

Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin.

Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC.

J Am Soc Nephrol. 2004 Jun;15(6):1392-401.

5.

[Cardiovascular system in patients in different stages of chronic kidney disease].

Strózecki P, Kozłowski M, Grajewska M, Kurowski R, Stefańska A, Odrowaź-Sypniewska G, Serafin Z, Lasek W, Nartowicz E, Kubica J, Manitius J.

Pol Merkur Lekarski. 2006 Aug;21(122):125-9; discussion 130-1. Polish.

PMID:
17144094
6.

[Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?].

Schlieper G, Brandenburg V, Djuric Z, Damjanovic T, Markovic N, Westenfeld R, Dimkovic N, Ketteler M, Floege J.

Dtsch Med Wochenschr. 2007 Sep;132(36):1820-4. German.

PMID:
17726653
7.

Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences.

Shobeiri N, Pang J, Adams MA, Holden RM.

J Hypertens. 2013 Jan;31(1):160-8. doi: 10.1097/HJH.0b013e32835b15bb.

PMID:
23183279
8.

Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model.

Ng K, Hildreth CM, Phillips JK, Avolio AP.

Am J Physiol Renal Physiol. 2011 Jun;300(6):F1431-6. doi: 10.1152/ajprenal.00079.2011. Epub 2011 Apr 6.

9.

Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.

Noonan W, Koch K, Nakane M, Ma J, Dixon D, Bolin A, Reinhart G.

Nephrol Dial Transplant. 2008 Dec;23(12):3824-30. doi: 10.1093/ndt/gfn375. Epub 2008 Jul 20.

PMID:
18644798
10.

Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.

Wang MC, Tsai WC, Chen JY, Huang JJ.

Am J Kidney Dis. 2005 Mar;45(3):494-501.

PMID:
15754271
11.

Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia.

London GM, Marchais SJ, Guérin AP, Métivier F.

Curr Opin Nephrol Hypertens. 2005 Nov;14(6):525-31. Review.

PMID:
16205470
12.

Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4.

Ford ML, Tomlinson LA, Smith ER, Rajkumar C, Holt SG.

Nephrol Dial Transplant. 2010 Jun;25(6):1853-8. doi: 10.1093/ndt/gfp723. Epub 2010 Jan 14.

PMID:
20075438
13.

Growth-associated hyperphosphatemia in young recipients accelerates aortic allograft calcification in a rat model.

Yamauchi H, Motomura N, Chung UI, Sata M, Takai D, Saito A, Ono M, Takamoto S.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):522-30. doi: 10.1016/j.jtcvs.2012.03.010. Epub 2012 Apr 17.

14.

Opposing changes in thoracic and abdominal aortic biomechanical properties in rodent models of vascular calcification and hypertension.

Ameer OZ, Salman IM, Avolio AP, Phillips JK, Butlin M.

Am J Physiol Heart Circ Physiol. 2014 Jul 15;307(2):H143-51. doi: 10.1152/ajpheart.00139.2014. Epub 2014 May 16.

15.

Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.

Larivière R, Gauthier-Bastien A, Ung RV, St-Hilaire J, Mac-Way F, Richard DE, Agharazii M.

J Hypertens. 2017 Feb;35(2):376-384. doi: 10.1097/HJH.0000000000001161.

PMID:
28005706
16.

Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.

Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG.

Nephrol Dial Transplant. 2012 May;27(5):1957-66. doi: 10.1093/ndt/gfr609. Epub 2011 Nov 20.

PMID:
22105144
17.

Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus.

Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Pratt JE, Tracy RP, Kuller LH, Manzi S.

Arthritis Rheum. 2004 Jan;50(1):151-9.

18.

Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease.

Gauthier-Bastien A, Ung RV, Larivière R, Mac-Way F, Lebel M, Agharazii M.

Clin Exp Hypertens. 2014;36(3):173-80. doi: 10.3109/10641963.2013.804541. Epub 2013 Jun 20.

PMID:
23786435
19.

Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.

Tatsumoto N, Yamada S, Tokumoto M, Eriguchi M, Noguchi H, Torisu K, Tsuruya K, Kitazono T.

Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F967-79. doi: 10.1152/ajprenal.00669.2014. Epub 2015 Sep 2.

20.

IL-18 is involved in vascular injury in end-stage renal disease patients.

Porazko T, Kúzniar J, Kusztal M, Kúzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M.

Nephrol Dial Transplant. 2009 Feb;24(2):589-96. doi: 10.1093/ndt/gfn486. Epub 2008 Sep 4.

PMID:
18775894

Supplemental Content

Support Center